ANDREW P BALBAUGH
Allopathic & Osteopathic Physicians|Internal Medicine GEORGETOWN, KY NPI 1265640411
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine KY GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$7,325.15
- Category: General Payments
- Program years: PY2018–2024
- Record count: 465
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,677.63 across 95 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,677.63 | 95 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $306.65 | 17 |
| Acerta Pharma LLC | $236.47 | 11 |
| ABBVIE INC. | $232.81 | 17 |
| Novo Nordisk AS | $139.10 | 7 |
| Corium, Inc. | $126.30 | 9 |
| Grifols USA, LLC | $122.20 | 5 |
| PFIZER INC. | $91.63 | 4 |
| Lilly USA, LLC | $76.19 | 4 |
| IRONSHORE PHARMACEUTICALS INC. | $47.86 | 3 |
| SANOFI-AVENTIS U.S. LLC | $38.86 | 2 |
| Cranial Technologies, Inc | $33.85 | 2 |
| DEXCOM, INC. | $28.96 | 2 |
| Exact Sciences Corporation | $26.66 | 2 |
| Axsome Therapeutics, Inc. | $26.20 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.81 | 1 |
| Azurity Pharmaceuticals, Inc. | $21.49 | 1 |
| Almatica Pharma Inc. | $16.82 | 1 |
| Neurocrine BioSciences, Inc. | $14.74 | 1 |
| Merck Sharp & Dohme Corporation | $14.70 | 1 |
| Seqirus USA Inc | $14.45 | 1 |
| Vertical Pharmaceuticals, LLC | $13.98 | 1 |
| Kowa Pharmaceuticals America, Inc. | $13.57 | 1 |
| Endogastric Solutions, Inc | $12.33 | 1 |
By program year
Records — PY2024 (95)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.